SPC
AMAG

Silver Point Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Silver Point Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-269,700
Closed -$14.7M – 19
2015
Q1 		$14.7M Sell
269,700
-166,300
-38% -$7.93M 1.54% 12
2014
Q4 		$18.6M Buy
+436,000
New +$15.8M 1.76% 13

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Silver Point Capital's AMAG Position: Q2 2015 in Review

Silver Point Capital sold out of AMAG Pharmaceuticals (AMAG) in Q2 2015, closing a stake of 269,700 shares — an estimated $14.7M sold.

Silver Point Capital first reported a position in AMAG in Q4 2014 and held it in 2 quarters. The position peaked at $18.6M in Q4 2014. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

  • Silver Point Capital reported no remaining AMAG Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Silver Point Capital sold 269,700 AMAG Pharmaceuticals shares in Q2 2015, an estimated $14.7M.
  • Silver Point Capital first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Silver Point Capital's AMAG Pharmaceuticals position peaked at $18.6M in Q4 2014.
  • 208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on Silver Point Capital's 13F filing for Q2 2015, filed 14 Aug 2015.